Fujifilm to buy Takeda's research chemical arm: sources

/ Nov 3, 2016

Fujifilm to buy Takeda's research chemical arm: sources

Fujifilm Holdings Corp. will purchase Takeda Pharmaceutical Co.’s research chemical unit for roughly ¥200 billion ($1.94 billion) to improve its medical business, sources familiar with the plan said Thursday. Last month, Fujifilm made a successful bid for Wako Pure Chemical Industries Ltd., Japan’s top ...

U.S. agency helps fund Takeda effort to develop Zika vaccine

Sep 2, 2016

U.S. agency helps fund Takeda effort to develop Zika vaccine

Japanese drugmaker Takeda Pharmaceutical Co. on Thursday said it is developing a vaccine to prevent the Zika virus, which has been linked to severe birth defects, and has secured funding from a U.S. government agency. Takeda, which is also working on vaccines for other ...

/ Oct 15, 2015

Heavy demand leads to mumps vaccine shortage

Vaccines for mumps are in short supply across the country due to heavier-than-expected demand, sources say. Drugmakers have started to notify medical institutions of the situation, although the shortfall is expected to be alleviated between next week and late November, the sources said. Some ...

Takeda gains first foreign chief as Weber is appointed CEO

/ Mar 5, 2015

Takeda gains first foreign chief as Weber is appointed CEO

Takeda Pharmaceutical Co. has named Christophe Weber chief executive officer as part of a planned succession that makes the French national one of the few international executives to lead a Japanese company. Weber, currently the chief operating officer, takes the new position effective April ...

/ Oct 29, 2014

U.S. court slashes Takeda damages over Actos drug

A U.S. district court in Louisiana has substantially reduced the amount of punitive damages it ordered Takeda Pharmaceutical Co. to pay for concealing the cancer risks of its diabetes drug Actos, a company spokesman said. The court cut the penalty imposed on the major ...